Gemtuzumab Ozogamicin is a promising post-remission therapy for acute myeloid leukemia

被引:2
|
作者
El Kinge, Abdul Rahman
Hatourn, Hassan A.
Mahfouz, Rami A. [2 ]
Otrock, Zaher K. [2 ]
Jabbour, Elias [3 ]
Kantarjian, Hagop [3 ]
Bazarbachi, Ali [1 ]
机构
[1] Amer Univ Beirut, Med Ctr, Dept Internal Med, Bone Marrow Transplantat Program, Beirut, Lebanon
[2] Amer Univ Beirut, Med Ctr, Dept Pathol & Lab Med, Beirut, Lebanon
[3] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
关键词
ACUTE MYELOGENOUS LEUKEMIA; RELAPSE; CHEMOTHERAPY; PROPOSAL;
D O I
10.1016/j.leukres.2008.05.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:565 / 566
页数:2
相关论文
共 50 条
  • [21] Optimal dosing of cytarabine in induction and post-remission therapy of acute myeloid leukemia
    Walter, Roland B.
    Appelbaum, Frederick R.
    Estey, Elihu H.
    LEUKEMIA, 2021, 35 (02) : 295 - 298
  • [22] Post-remission therapy in acute myeloid leukemia: Are we ready for an individualized approach?
    Derman, Benjamin A.
    Larson, Richard A.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2019, 32 (04)
  • [23] The Value of Post-Remission Therapy in Older Adults with Acute Myeloid Leukemia (AML).
    Sekeres, Mikkael A.
    Fu, Alex Z.
    Earl, Marc
    Kalaycio, Matt
    Advani, Anjali
    Saunthararajah, Yogen
    Sobecks, Ronald
    Copelan, Edward
    BLOOD, 2009, 114 (22) : 431 - 432
  • [24] Optimal dosing of cytarabine in induction and post-remission therapy of acute myeloid leukemia
    Roland B. Walter
    Frederick R. Appelbaum
    Elihu H. Estey
    Leukemia, 2021, 35 : 295 - 298
  • [25] Antibody-based therapy of acute myeloid leukemia with gemtuzumab ozogamicin
    Cowan, Andrew J.
    Laszlo, George S.
    Estey, Elihu H.
    Walter, Roland B.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2013, 18 : 1312 - 1335
  • [26] Efficacy and resistance of gemtuzumab ozogamicin for acute myeloid leukemia
    Akihiro Takeshita
    International Journal of Hematology, 2013, 97 : 703 - 716
  • [27] Gemtuzumab ozogamicin in the treatment of acute myeloid leukemia.
    Stadtmauer E.A.
    Current Oncology Reports, 2002, 4 (5) : 375 - 380
  • [28] Efficacy and resistance of gemtuzumab ozogamicin for acute myeloid leukemia
    Takeshita, Akihiro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (06) : 703 - 716
  • [29] Gemtuzumab ozogamicin for the treatment of acute myeloid leukemia in adults
    Goldenson, Benjamin H.
    Goodman, Aaron M.
    Ball, Edward D.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (07) : 849 - 862
  • [30] Gemtuzumab Ozogamicin In Refractory Childhood Acute Myeloid Leukemia
    Reinhardt, Dirk
    Zwaan, Christian M.
    Sander, Annette
    Neuhoff, Christine
    Kaspers, Gertjan J.
    Creutzig, Ursula
    BLOOD, 2010, 116 (21) : 470 - 470